MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SNGX had $5,427,665 increase in cash & cash equivalents over the period. -$2,933,222 in free cash flow.

Cash Flow Overview

Change in Cash
$5,427,665
Free Cash flow
-$2,933,222

Unit: Dollar
Cash Flow
2025-09-30
2025-06-30
Net loss
-2,530,947 -5,653,244
Amortization and depreciation
911 1,311
Non-cash lease expense
26,889 60,263
Share-based compensation
104,346 163,112
Issuance of common stock to vendors for services
46,600 30,000
Prepaid expenses and other current assets
164,478 -714,169
Operating lease liability
-26,349 -61,062
Accounts payable and accrued expenses
-375,216 405,869
Accrued compensation
-14,370 -249,253
Net cash flows from operating activities
-2,932,614 -4,588,835
Purchases of office furniture and equipment
608 3,313
Net cash flows from investing activities
-608 -3,313
Proceeds from issuance of common stock pursuant to at market issuance sales agreement
1,423,244 3,243,177
Proceeds from issuance of common stock and pre-funded warrants
7,498,522 -
Stock issuance costs associated-Public Offering
562,370 -
Proceeds from the exercise of warrants
1,491 -
Convertible debt repayments
0 1,372,873
Net cash flows from financing activities
8,360,887 1,870,304
Net increase in cash and cash equivalents
5,427,665 -2,721,844
Cash and cash equivalents at beginning of period
7,819,514 -
Cash and cash equivalents at end of period
10,525,335 -
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

SOLIGENIX, INC. (SNGX)

SOLIGENIX, INC. (SNGX)